Skip to content

Clinical trials

Completed Phase 1/2 Ovarian Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1/2 Status: Completed Clear all

115 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20013
20021
20035
20045
20056
20064
20073
20082
20094
20105
20114
20125
20134
20145
20155
20168
201711
20185
20196
20202
20212
20224
20234

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed115

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center5
National Cancer Institute (NCI)4
Incyte Biosciences International Sàrl3
Incyte Corporation3
AGO Study Group2
ARCAGY/ GINECO GROUP2
Duke University2
European Organisation for Research and Treatment of Cancer - EORTC2
Fred Hutchinson Cancer Center2
Fuda Cancer Hospital, Guangzhou2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms115
Breast Neoplasms25
Carcinoma, Ovarian Epithelial21
Fallopian Tube Neoplasms21
Carcinoma, Non-Small-Cell Lung20
Colorectal Neoplasms17
Neoplasms16
Endometrial Neoplasms15
Melanoma15
Pancreatic Neoplasms15

Trials

Showing 1 to 25 of 115. Each trial links to its page on Pharma Observatory.

15 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.